224: Usefulness of non invasive ambulatory blood pressure monitoring (ABPM) in chronic dialysis patients (CDP)
| Autor: | Hédi Baccar, Wejdène Ouechtati, E. Allouche, Habib Ben Ahmed, Imen Fradi El Felah |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Ambulatory blood pressure Anemia business.industry medicine.medical_treatment Retrospective cohort study medicine.disease Muscle hypertrophy Surgery carbohydrates (lipids) Blood pressure Chronic dialysis Internal medicine medicine Cardiology lipids (amino acids peptides and proteins) Circadian rhythm business Cardiology and Cardiovascular Medicine Dialysis |
| Zdroj: | Archives of Cardiovascular Diseases Supplements. 5(1) |
| ISSN: | 1878-6480 |
| DOI: | 10.1016/s1878-6480(13)71155-8 |
| Popis: | Introduction Arterial hypertension (AH) is a potent factor of cardiovascular death in chronic dialysis patients (CDP). Development of ambulatory blood pressure monitoring (ABPM) allowed a better analysis of inter dialysis blood pressure (BP) profile. We studied the relationship between ABPM findings and clinical and biological data in CDP, to determinate its clinical application. Methods Retrospective study of 24 hours ABPM (after dialysis) in 28 CDP divided into 3 groups according to pre dialyses BP profile: G1: CDP with controlled AH (n=8) G2: CDP with un-controlled AH (n=12) G3: CDP without AH (n=8) Results ABPM findings are correlated to clinical BP measurements before and after dialysis. Mean systolic ABP is lower than pre dialysis clinical BP. 82% of CDP loose the BP circadian cycle. 64,3% of CDP and 83,3% of patients with AH had echocardiographic left ventricular (LV) hypertrophy. LV mass is correlated to BP load, the anemia's severity, the loss of the BP circadian cycle and the use of acetate in dialysis bath. Conclusion ABPM in CDP has various clinical applications: • diagnosis of AH • Evaluation of AH treatment • Evaluation of cardiovascular death risk |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect